General
Preferred name
FLUMETHASONE
Synonyms
flumetasone ()
RS-2177 ()
NSC-54702 ()
flumethasone pivalate ()
RS-2177, NSC-54702,Flumetasone ()
U-10,974 ()
Flumetasona ()
Flucort ()
Flumetasone ()
U-10974 ()
P&D ID
PD012034
CAS
2135-17-3
Tags
available
drug
Approved by
FDA
Drug Status
vet_approved
approved
withdrawn
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Flumethasone (Flumetasone) is an orally active, high selective and potent glucocorticoid receptor (GR) agonist. Flumethasone activates GR to inhibit nuclear factor kappa B (NF-¦ÊB)-mediated pro-inflammatory cytokine production (TNF-¦Á, IL-1¦Â) and promotes anti-inflammatory gene expression (IL-10), while also regulating metabolic enzyme activity (tyrosine aminotransferase induction). Flumethasone is promising for research of inflammatory diseases, cancer, and endocrine regulation[1][2][3][4].
DESCRIPTION
Flumethasone (RS-2177) is a glucocorticoid receptor agonist, with anti-inflammatory, antipruritic and vasoconstrictive properties.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
15
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
410.19
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
4
Aromatic Ring Count
0
cLogP
1.84
TPSA
94.83
Fraction CSP3
0.73
Chiral centers
9.0
Largest ring
6.0
QED
0.65
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Glucocorticoid Receptor
NR3C1, PLA2G1B
Glucocorticoid agonist
Interleukin Related
Keap1-Nrf2
TNF Receptor
Disease Area
otolaryngology, infectious disease, dermatology
Indication
otitis, ear infections, corticosteroid-responsive dermatoses
MOA
Glucocorticoid Receptor agonist
ATC
D07AB03
D07XB01
H02AB90
Pathway
Apoptosis
Immunology/Inflammation
NF-κB
Vitamin D Related/Nuclear Receptor
Endocrinology/Hormones
NF-¦ÊB
Source data

